Evidence map›Paper›PMID 33112208›Full record

ReviewCell cycle (Georgetown, Tex.)2020

HOPS and p53: thick as thieves in life and death.

Maria Agnese Della-Fazia, Marilena Castelli, Danilo Piobbico, Stefania Pieroni, Giuseppe Servillo

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. International journal of molecular sciences · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maria Agnese Della-FaziaDepartment of Experimental Medicine, University of Perugia , Perugia, Italy.ORCID 0000-0002-5373-8477
Marilena CastelliDepartment of Experimental Medicine, University of Perugia , Perugia, Italy.
Danilo PiobbicoDepartment of Experimental Medicine, University of Perugia , Perugia, Italy.
Stefania PieroniDepartment of Experimental Medicine, University of Perugia , Perugia, Italy.
Giuseppe ServilloDepartment of Experimental Medicine, University of Perugia , Perugia, Italy.ORCID 0000-0001-7960-7689
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncosuppressor protein p53 plays a major role in transcriptionally controlling the expression of a number of genes, which in turn regulates many functions in response to DNA damage, oncogene triggering, oxidative, and additional cell stresses. A developing area of interest in p53 is the studies related to its cytoplasmic function(s). Many investigations revealed the significant role of p53 in the cytoplasm, acting in a transcriptional-independent manner in important processes related to cell homeostasis such as; apoptosis, autophagy, metabolism control, drug, and oxidative stress response. The studies on cytoplasmic p53 have shown intricate mechanisms by which posttranslational modifications allow p53 to perform its cytoplasmic functions. A number of ubiquitins, deubiquitins, and small ubiquitin-like proteins, have a pivotal role in controlling cytoplasmic stability and localization. Recently, HOPS/TMUB1 a novel small ubiquitin-like protein has been described as a vital molecule stabilizing p53 half-life, directing it to the mitochondria and favoring p53-mediated apoptosis. Furthermore, HOPS/TMUB1 competing with importin-α lessens p53 nuclear localization, thereby increasing cytoplasmic concentration. HOPS/TMUB1 as p53 modifiers could be attractive candidates to elucidate apoptosis or other important transcriptional-independent functions which are key in cancer research in order to develop new therapeutic approaches.

Indexed as

AnimalsApoptosisCarrier ProteinsCell NucleusCytoplasmDNA DamageHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceMice, KnockoutMitochondriaNeoplasmsNuclear ProteinsSignal TransductionTumor Suppressor Protein p53Carrier ProteinsHOPS protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsNuclear ProteinsTumor Suppressor Protein p53ApoptosisHepatocyte Odd Protein Shuttling (HOPS)Liver regenerationMitochondrial ApoptosisNucleophosmin (NPM)/p19 Arfp53Transmembrane and ubiquitin-like domain containing 1 (TMUB1)Tumor Suppressor GeneUbiquitin–Like Protein

Identifiers

PMID33112208
PMCPMC7714459
OpenAlexW3095824494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.